We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current GMDA market cap is 4.34M. The company's latest EPS is USD -0.4749 and P/E is -0.06.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 673k |
| Operating Income | -17.06M | -20.56M | -19.58M | -18.8M | -27.48M |
| Net Income | -17.8M | -22.8M | -20.96M | -31.68M | -1.52M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 1.78M |
| Operating Income | -48.25M | -62.3M | -87.17M | -74.99M | -73.04M |
| Net Income | -34.35M | -72.7M | -89.79M | -79.38M | -63M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 114.31M | 124.77M | 105.13M | 112.51M | 117.75M |
| Total Liabilities | 100.75M | 132.8M | 120.5M | 138.22M | 117.37M |
| Total Equity | 13.56M | -8.02M | -15.37M | -25.71M | 382k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 68.78M | 155.48M | 148.79M | 124.77M | 102.19M |
| Total Liabilities | 33.79M | 56.75M | 104.85M | 132.8M | 105.14M |
| Total Equity | 34.98M | 98.74M | 43.94M | -8.02M | -2.95M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -54.25M | -70.42M | -22.28M | -44.29M | -62.86M |
| Investing | 31.05M | 34.04M | -827k | -821k | -539k |
| Financing | 22.37M | 45.14M | 5.22M | 34.66M | 59.17M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -37.93M | -48.63M | -81.76M | -70.42M | -79.12M |
| Investing | 3.67M | 1.59M | -60.92M | 34.04M | -810k |
| Financing | 35.73M | 132.38M | 71.4M | 45.14M | 61.77M |
| Market Cap | 4.34M |
| Price to Earnings Ratio | -0.06 |
| Price to Sales Ratio | 2.22 |
| Price to Cash Ratio | 0.09 |
| Price to Book Ratio | -1.35 |
| Dividend Yield | - |
| Shares Outstanding | 132.64M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 44.08M |
| 52 Week Change | -97.88% |
| 52 Week High | 2.51 |
| 52 Week Low | 0.0303 |
| Spread (Intraday) | 0 (0.66%) |
| Company Name | Gamida Cell Ltd |
| Address |
5 nahum heftsadie street jerusalem, jerusalem 91340 |
| Website | https://www.gamida-cell.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
